Home/Filings/4/0001209191-22-014621
4//SEC Filing

Mano Michael 4

Accession 0001209191-22-014621

CIK 0001503802other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 3:14 PM ET

Size

7.4 KB

Accession

0001209191-22-014621

Insider Transaction Report

Form 4
Period: 2022-02-28
Mano Michael
SVP, General Counsel&Secretary
Transactions
  • Award

    Common Stock

    2022-02-28+63,00063,000 total
  • Award

    Stock Option (right to buy)

    2022-02-28+81,00081,000 total
    Exercise: $10.33Exp: 2032-02-27Common Stock (81,000 underlying)
Footnotes (2)
  • [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 28, 2023.
  • [F2]This option was granted on February 28, 2022 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Issuer

Karyopharm Therapeutics Inc.

CIK 0001503802

Entity typeother

Related Parties

1
  • filerCIK 0001837741

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 3:14 PM ET
Size
7.4 KB